A six-gene signature (CLC, CPA3, DNASE1L3, IL1B, ALPL, and CXCR2) can differentiate asthma patients from controls, discriminate inflammatory phenotypes of asthma and predict the ICS response [67], but this method is not currently available. This evidence concerns the gene IL1B and asthma.